Surgery Partners, Inc. (SGRY): Price and Financial Metrics

Surgery Partners, Inc. (SGRY)

Today's Latest Price: $36.54 USD

6.07 (19.92%)

Updated Jan 28 11:13am

Add SGRY to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 78 in Medical - Services

See all "A" rated Strong Buy stocks

SGRY Stock Summary

  • Surgery Partners Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than 98.4% of US listed stocks.
  • SGRY's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of 98.4% of US stocks.
  • In terms of twelve month growth in earnings before interest and taxes, Surgery Partners Inc is reporting a growth rate of -565.87%; that's higher than only 3.45% of US stocks.
  • If you're looking for stocks that are quantitatively similar to Surgery Partners Inc, a group of peers worth examining would be CLPR, AES, CLF, CVI, and GTN.
  • Visit SGRY's SEC page to see the company's official filings. To visit the company's web site, go to

SGRY Stock Price Chart Interactive Chart >

Price chart for SGRY

SGRY Price/Volume Stats

Current price $36.54 52-week high $37.78
Prev. close $30.47 52-week low $4.00
Day low $31.57 Volume 2,077,211
Day high $37.78 Avg. volume 389,614
50-day MA $28.16 Dividend yield N/A
200-day MA $19.59 Market Cap 1.85B

Surgery Partners, Inc. (SGRY) Company Bio

Surgery Partners Inc. is a healthcare services company focused on providing high-quality, cost-effective solutions for surgical and related ancillary care in support of the company's patients and physicians. The company was founded in 2004 and is based in Nashville, Tennessee.

SGRY Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$36.54$71.78 147%

The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Surgery Partners Inc. To summarize, we found that Surgery Partners Inc ranked in the 70th percentile in terms of potential gain offered. More precisely, our analysis suggests the stock is undervalued by approximately 148% on a DCF basis. The most interesting components of our discounted cash flow analysis for Surgery Partners Inc ended up being:

  • Interest coverage, a measure of earnings relative to interest payments, is 0.22 -- which is good for besting just 24.78% of its peer stocks (US stocks in the Healthcare sector with positive cash flow).
  • 31% of the company's capital comes from equity, which is greater than only 9.14% of stocks in our cash flow based forecasting set.
  • Surgery Partners Inc's effective tax rate, as measured by taxes paid relative to net income, is at 0 -- greater than only 0% of US stocks with positive free cash flow.

Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price

Want more companies with a valuation profile/forecast similar to that of Surgery Partners Inc? See ESMC, ABBV, CSTL, LH, and ALXN.

SGRY Latest News Stream

Event/Time News Detail
Loading, please wait...

SGRY Latest Social Stream

Loading social stream, please wait...

View Full SGRY Social Stream

Latest SGRY News From Around the Web

Below are the latest news stories about Surgery Partners Inc that investors may wish to consider to help them evaluate SGRY as an investment opportunity.

Surgery Partners, Inc. Announces Proposed Public Offering of Common Stock

BRENTWOOD, Tenn., Jan. 25, 2021 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (Nasdaq: SGRY) (“Surgery Partners”) today announced that it has commenced an underwritten public offering of 6,000,000 shares of its common stock. All of the shares to be sold in the offering are to be sold by Surgery Partners. In connection with the offering, Surgery Partners intends to grant the underwriters a 30-day option to purchase up to an additional 900,000 shares of its common stock. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. J.P. Morgan Securities LLC and Jefferies LLC are acting as lead bookrunning managers, and Barclays Capital Inc., KKR Capital Markets LLC...

Yahoo | January 25, 2021

10 Best Mid-Cap Stocks To Buy According To Billionaire Brian Higgins

In this article, we presented the 10 best mid-cap stocks to buy according to billionaire Brian Higgins. Click to skip ahead and see the 5 Best Mid-Cap Stocks To Buy Billionaire Brian Higgins. Billionaire Brian Higgins, 55, is the co-founder of investment management firm King Street Capital Management. The New York-based firm is managing $17 […]

Yahoo | January 16, 2021

Surgery Partners reaffirmed FY20 adj. EBITDA guidance, provides FY21 initial adj. EBITDA outlook

For FY20, Surgery Partners (SGRY) provided revenue guidance of ~$1.86B and reaffirmed its previous FY20 adj. EBITDA guidance range of $250 to $260M.Consistent with previous management statements, the company projects that in 2021, it will re-establish the multi-year double-digit; adj. growth trajectory and profit levels originally targeted based on a...

Seeking Alpha | January 11, 2021

RBC Capital Stick to Their Buy Rating for Surgery Partners Inc

RBC Capital Stick to Their Buy Rating for Surgery Partners Inc | January 5, 2021

Construction Partners, Surgery Partners, Qualcomm, AbbVie and Garmin as Zacks Bull and Bear of the Day

Construction Partners, Surgery Partners, Qualcomm, AbbVie and Garmin as Zacks Bull and Bear of the Day

Yahoo | December 23, 2020

Read More 'SGRY' Stories Here

SGRY Price Returns

1-mo 26.48%
3-mo 67.46%
6-mo 139.29%
1-year 104.71%
3-year 138.05%
5-year 126.82%
YTD 25.96%
2020 85.31%
2019 59.91%
2018 -19.09%
2017 -23.66%
2016 -22.65%

Continue Researching SGRY

Want to see what other sources are saying about Surgery Partners Inc's financials and stock price? Try the links below:

Surgery Partners Inc (SGRY) Stock Price | Nasdaq
Surgery Partners Inc (SGRY) Stock Quote, History and News - Yahoo Finance
Surgery Partners Inc (SGRY) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.9365 seconds.